Cognition Therapeutics Inc
NASDAQ:CGTX
Earnings Announcements
Cognition Therapeutics Provides Business Update
Published: 03/30/2022 11:12 GMT
Cognition Therapeutics Inc (CGTX) - Cognition Therapeutics Inc - Has Sufficient Cash to Fund Operations and Capital Expenditures Into Second Half of 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.29
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.35
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.29
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.35
More details on our Analysts Page.